Genetics in the Progression of Nephropathies - Trial NCT06416761
Access comprehensive clinical trial information for NCT06416761 through Pure Global AI's free database. This phase not specified trial is sponsored by Ospedale San Raffaele and is currently Recruiting. The study focuses on AKI,CKD,Ckd-Mbd,CKD (Chronic Kidney Disease) Stage 5D,ADPKD,Hypertension,Hematologic Malignancy,Bone Marrow Transplant Complications. Target enrollment is 10000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
genetic polymorphisms
Observational
genetic
Sponsor & Location
Ospedale San Raffaele
Timeline & Enrollment
N/A
May 19, 2006
May 19, 2041
Primary Outcome
difference in glomerular filtration rate according to genetic profile
Summary
This study evaluates the role of genetic in the development and progression of different
 nephropaties with particular attention to:
 
 - AKI
 
 - CKD
 
 - Hypertension
 
 - ADPKD
 
 - CKD-MBD
 
 - Patients with decompensated heart failure undergoing either medical or surgery therapy
 
 - Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing
 allogeneic bone marrow transplantation
 
 - glomerular diseases
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06416761
Non-Device Trial